A phase II trial of chemotherapeutic agents in patients with diffuse large B-Cell lymphoma

BH-15-022
Cancer - Lymphoma, Cancer
Syed Ali, MD

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA

Baystate Franklin Medical Center
164 High Street
Greenfield, MA

The purpose of this study is to find out what effects, good and/or bad, the addition of lenalidomide to standard chemotherapy (RCHOP)
Newly diagnosed diffuse large B-cell lymphoma expressing CD20 antigen
Katie Colbeck
413-794-9875